Investing where it matters most
We have always viewed R&D as essential to our growth. That is why we are committed to making a significant investment towards it year after year. In fact, over 11% of our employees are engaged full-time in R&D, and a total amount of €106 million was invested in R&D in 2020.
Innovation is at our core
In 2017, we proudly built a new R&D site in the Barcelona area, Spain. This new facility marks the latest chapter in our long history of innovation and we now have nine state-of-the-art R&D and manufacturing facilities - from Europe to North America - that help us maintain our vigorous commitment to progress and advancement around the world.
These facilities are located in Ascoli (Italy), Barcelona (Spain), Bedford, Massachusetts (USA), Munich (Germany), Orangeburg, New York (USA), and San Diego, California (USA).
Decades of innovations
Thanks to our continuous investment in R&D and dedicated specialized teams, we have been at the forefront of decades of landmark discoveries, including the first direct-reading pH/blood gas analyzer and the invention of CO-oximetry, the first fully automated coagulation system, as well as more than 50 biomarkers in the autoimmunity market.
1959
pH/Blood Gas Analyzer
IL 105 – The first direct-reading pH/blood gas analyzer
1967
CO-oximetry
IL182 – Invention of the technique that measures total hemoglobin and oxygenation parameters
2000
GEM® PremierTM 3000
The first multi-test cartridge standardized Acute Care testing platform for all hospital locations
2004
ACL TOP®
The most advanced platform for automated Hemostasis testing
2006
GEM® PremierTM 4000
The only single-component, multi-use cartridge analyzer with integrated CO-oximetry
2008
ACL TOP® 500
The system that delivers Testing Process Automation for mid- to high-volume laboratories
2009
ACL AcuStar®
The first, and only, fully-automated high-sensitivity immunoassay system for Hemostasis testing
2010
Quanta Link®
The easy-to-use workflow management system that gives you immediate control of all your autoimmune IFA, EIA, and chemiluminescence sample processing
2010
Nova View®
The fully automated IFA microscope - combined with an intelligent digital imaging system - that reads and archives images of IFA-stained slides
2011
BIO-FLASH®
The fully automated, random access chemiluminescent platform for high-sensitivity magnetic particle based on immunoassays
2012
ACL TOP® 300 CTS
The system that delivers Testing Process Automation for mid- to high-volume laboratories
2012
Integrated Lab for Autoimmunity
The concept of seamlessly connecting our autoimmunity instruments to the LIS by a centralized data management system
2013
QUANTA Flash®
The immunoassays indicated for semi-quantitative determination of autoantibodies that offer faster response and broader dynamic range than enzyme-based assays for more precise quantification and confidence in result
2015
ACL TOP® Family 50 Series
The breakthrough Hemostasis analyzer with pre-analytical sample check
2016
GEM® PremierTM 5000
The system with Intelligent Quality Management 2 (iQM®2) that enables rapid, quality-assured test results with every sample
2016
QUANTA-Lyser® 4000
The ultra-high throughput IFA processor that reduces hands-on time, safeguards reagent and sample integrity, and accelerates processing speed
2016
GEMweb® Plus 500 Custom Connectivity
The data management system that simplifies operator supervision, provides quality management and full traceability, all from a single interface
2016
HemoHub™ Intelligent Data Manager
The information management solution for Hemostasis laboratories
